Prostate Cancer Susceptibility Candidate (PRAC) (N-Term) Peptid
PRAC
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN982155
Kurzübersicht für Prostate Cancer Susceptibility Candidate (PRAC) (N-Term) Peptid (ABIN982155)
Target
PRAC
(Prostate Cancer Susceptibility Candidate (PRAC))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequenz
- DQGPAHLTTS KSAFLSNKKT STLKHLLGET RSDGSACNSG ISGGRGRKIP
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-PRAC Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
-
Hintergrund
-
This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus.
Alias Symbols: C17orf92, MGC32520
Protein Size: 57 -
Molekulargewicht
- 6 kDa
-
Gen-ID
- 84366
-
NCBI Accession
- NM_032391, NP_115767
-
UniProt
- Q96KF2
Target
-
Sie sind hier:
